We are thrilled to announce that Dr. Istvan Petak, founder and CEO of Genomate Health, will pitch at Digital Health Rewired 2025 Pitchfest, the UK’s premier digital health event. Taking place at The NEC in Birmingham on March 19, from 14:45 to 14:55, Istvan will present Genomate® in the Pre-revenue Generating Start-ups category, showcasing how our computational intelligence-powered solution is set to transform precision oncology.

Genomate® was founded to address a critical challenge in cancer treatment: the gap between molecular data, computational power, and actionable clinical decisions. With cancer being a leading cause of mortality worldwide and the cost of ineffective treatments burdening both patients and insurers, the need for precision oncology has never been more urgent. Genomate® enhances treatment selection and improves patient outcomes by providing clinicians with comprehensive molecular insights. The impact extends beyond individual cases, offering healthcare systems a more efficient, cost-effective approach to cancer care.

The UK faces an urgent cancer crisis, with 472,000 new cases expected in 2025 (source). Despite advancements in treatment, 93% of cancer patients do not benefit from targeted therapies due to the complex nature of tumors, which typically involve 4-5 key driver mutations among 700+ cancer-related genes. This complexity makes it incredibly difficult to pinpoint the right therapeutic targets. Genomate Health’s approach helps clinicians navigate this challenge, providing precision molecular diagnostics that enable more effective, personalized treatment strategies, improving survival rates and reducing unnecessary healthcare costs.

At Pitchfest, Istvan will share the company’s journey, from identifying this pressing healthcare gap to developing advanced molecular diagnostics powered by computational intelligence that enhance treatment decisions. With cancer care evolving rapidly, Genomate Health’s solutions are designed to streamline clinical workflows, improve survival rates, and ultimately reduce the economic burden of cancer treatment in the UK and globally.

Join us at Digital Health Rewired 2025 to explore the future of digital health innovation.